Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Potential of New Tests in Long-Term Diabetes Complications

By LabMedica International staff writers
Posted on 22 Jan 2014
Glucose levels in diabetic patients should be constantly monitored, but the standard Hemoglobin A1c (HbA1c) test is not valid for everyone. More...
The test, which is also used to diagnose diabetes, reflects exposure to glucose in the blood over the previous 2–3 months. However, it will not work in patients with anemia, kidney disease, hemoglobinopathies, human immunodeficiency virus (HIV), and certain other conditions.

Scientists at Johns Hopkins University (Baltimore, MD, USA), the University of Wisconsin (UW; Madison, WI, USA), and the University of Minnesota (Minneapolis, MN, USA) measured HbA1c, fructosamine, and glycated albumin in blood samples from over 12,000 participants in the Atherosclerosis Risk in Communities (ARIC) Study. (The ARIC Study is a community-based cohort of persons from Washington County, MD; Jackson, MS; Forsyth County, NC; and suburban Minneapolis, MN who have been followed for clinical outcomes since 1987).

The investigators discovered that fructosamine tests and a novel assay for glycated albumin could be useful for predicting complications related to diabetes. The results of the study suggest that fructosamine and glycated albumin should be useful substitutes for monitoring glucose control in patients with diabetes when HbA1c is not available or not valid. Because fructosamine and glycated albumin are measures of short-term (2–4 week) glucose control and change more rapidly than HbA1c, they could also be useful for monitoring changes in diabetes treatments.

Fructosamine is approved for clinical use in the United States but rarely used. The glycated albumin test is widely used in Japan but not approved for use in the United States. A major barrier to using these nontraditional markers is that they have not been related to the clinical outcomes of diabetes or compared to HbA1c.

The study appears in the January 15, 2014, online addition of Lancet Diabetes & Endocrinology.

Elizabeth Selvin, PhD, MPH, associate professor, Johns Hopkins Bloomberg School of Public Health and senior author on the study remarked, “We compared the associations of HbA1c, fructosamine, and glycated albumin with two of the most important clinical outcomes related to diabetes: retinopathy and kidney disease. We found that fructosamine and glycated albumin were strongly associated with retinopathy and kidney disease. These associations were similar to those observed for HbA1c with these outcomes.”

However, Prof. Selvin added, “Further studies are needed to understand the value of these tests in the clinic.”

Related Links:

Johns Hopkins University
University of Wisconsin
University of Minnesota



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Silver Member
Vitamin D Assay
EZ Vitamin D Assay
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.